Targeted insurers Pharm3r’s PandoraPlus platform delivers post-market surveillance, adverse event analytics and regulatory intelligence tailored for life sciences insurers, presenting a clear opportunity to upsell enhanced risk monitoring and underwriting insights directly to leading insurers.

Regulatory risk With comprehensive regulatory intelligence covering FDA actions, recalls, and Health Canada records, Pharm3r can position its data assets to regulatory affairs teams seeking proactive compliance monitoring and early warning signals to mitigate enforcement risk.

Supply chain visibility Regulatory action coverage across 93,000+ facilities and product-to-facility mapping enables supply chain risk management use cases for manufacturers and distributors aiming to strengthen supplier risk programs and regulatory due diligence.

Clinical and safety insights Access to FAERS, MAUDE, and ClinicalTrials.gov data supports pharmacovigilance and safety analytics offerings that can be packaged for pharma, medical device firms, and CROs seeking real-time disproportionality signals and cross-trial safety benchmarking.

Evidence-driven expansion References to comprehensive portfolio management analytics and litigation intelligence present an opportunity to cross-sell to underwriters and corporate legal teams by highlighting concentration risk visualization and emerging safety risk indicators.